 NEW YORK, June 09, 2022 GLOBE NEWSWIRE -- Indaptus Therapeutics, Inc. Nasdaq: INDP Indaptus or the Company, today announced that Jeffrey A. Meckler, Chief Executive Officer of Indaptus, will present a corporate overview at the JMP Securities Life Sciences Conference on Thursday, June 16, 2022 at 2:30 p.m. ET in New York City. 